Ketamine use: a review.

AIMS Ketamine remains an important medicine in both specialist anaesthesia and aspects of pain management. At the same time, its use as a recreational drug has spread in many parts of the world during the past few years. There are now increasing concerns about the harmful physical and psychological consequences of repeated misuse of this drug. The aim of this review was to survey and integrate the research literature on physical, psychological and social harms of both acute and chronic ketamine use. METHOD The literature on ketamine was systematically searched and findings were classified into the matrix of Nutt et al.'s (2007) rational scale for assessing the harms of psychoactive substances. RESULTS A major physical harm is ketamine induced ulcerative cystitis which, although its aetiology is unclear, seems particularly associated with chronic, frequent use of the drug. Frequent, daily use is also associated with neurocognitive impairment and, most robustly, deficits in working and episodic memory. Recent studies suggest certain neurological abnormalities which may underpin these cognitive effects. Many frequent users are concerned about addiction and report trying but failing to stop using ketamine. CONCLUSIONS The implications of these findings are drawn out for treatment of ketamine-induced ulcerative cystitis in which interventions from urologists and from addiction specialists should be coordinated. Neurocognitive impairment in frequent users can impact negatively upon achievement in education and at work, and also compound addiction problems. Prevention and harm minimization campaigns are needed to alert young people to these harmful and potentially chronic effects of ketamine.

[1]  J. Krystal,et al.  Characterization of the Interactive Effects of Glycine and D-Cycloserine in Men: Further Evidence for Enhanced NMDA Receptor Function Associated with Human Alcohol Dependence , 2011, Neuropsychopharmacology.

[2]  J. Persson Wherefore ketamine? , 2010, Current opinion in anaesthesiology.

[3]  J. Bloom,et al.  Longitudinal trajectories of ketamine use among young injection drug users. , 2010, The International journal on drug policy.

[4]  Wei Hao,et al.  Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study. , 2010, Brain : a journal of neurology.

[5]  S. Ng,et al.  Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. , 2010, Hong Kong medical journal = Xianggang yi xue za zhi.

[6]  D. Charney,et al.  Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression , 2010, Biological Psychiatry.

[7]  Leslie Muetzelfeldt,et al.  Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. , 2010, Addiction.

[8]  J. Oxley,et al.  Ketamine cystitis as a mimic of carcinoma in situ , 2009, Histopathology.

[9]  R. Hese,et al.  [A case of ketamine dependence]. , 2009, Psychiatria polska.

[10]  T. Abel,et al.  Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials , 2009, Neurobiology of Disease.

[11]  N. Iacovidou,et al.  Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug , 2009, Journal of clinical pharmacology.

[12]  A. Loepke,et al.  General anesthetics and the developing brain , 2009, Current opinion in anaesthesiology.

[13]  S. Ng,et al.  Dilated common bile ducts in ketamine abusers. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

[14]  P. Lai,et al.  Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

[15]  P. Dargan,et al.  Epidemiology of Recreational Drug Toxicity in a Nightclub Environment , 2009, Substance use & misuse.

[16]  Leslie Muetzelfeldt,et al.  Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. , 2009, Addiction.

[17]  C. Man,et al.  The destruction of the lower urinary tract by ketamine abuse: a new syndrome? , 2008, BJU international.

[18]  D. Gillatt,et al.  THE DESTRUCTION OF THE LOWER URINARY TRACT BY KETAMINE ABUSE: A NEW SYNDROME? , 2008, BJU international.

[19]  G. Dureja,et al.  Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury , 2008, Journal of Brachial Plexus and Peripheral Nerve Injury.

[20]  D. Gillatt,et al.  Consider ketamine misuse in patients with urinary symptoms. , 2008, The Practitioner.

[21]  J. Wiley,et al.  PRECLINICAL STUDY: Age‐dependent differences in sensitivity and sensitization to cannabinoids and ‘club drugs’ in male adolescent and adult rats , 2008, Addiction biology.

[22]  Sunjeev K Kamboj,et al.  Journey through the K-hole: phenomenological aspects of ketamine use. , 2008, Drug and alcohol dependence.

[23]  F. Measham,et al.  It's the most fun you can have for twenty quid: Meanings, Motivations and Consequences of British Ketamine Use. , 2008 .

[24]  M. Grégoire,et al.  A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007). , 2008, Urology.

[25]  N. Kolhe,et al.  Obstructive nephropathy and kidney injury associated with ketamine abuse , 2008, NDT plus.

[26]  T. Tonia,et al.  Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006). , 2008, Journal of clinical psychopharmacology.

[27]  K. A. Trujillo,et al.  Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use , 2008, Biological Psychiatry.

[28]  C. Morgan,et al.  Attentional bias to incentive stimuli in frequent ketamine users , 2008, Psychological Medicine.

[29]  C. Griffin,et al.  Ketamine: The Divisive Dissociative. A Discourse Analysis of the Constructions of Ketamine by Participants of a Free Party (Rave) Scene , 2008 .

[30]  F. Measham,et al.  “It's the most fun you can have for twenty quid”: Motivations, Consequences and Meanings of British Ketamine Use , 2008 .

[31]  R. Newcombe Ketamine Case Study: The Phenomenology of a Ketamine Experience , 2008 .

[32]  R. Vanholder,et al.  Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies , 2007, NDT plus.

[33]  P. Meyer,et al.  Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists , 2007, Psychopharmacology.

[34]  B. K. Cheung,et al.  Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine. , 2007, Forensic science international.

[35]  E. Rabiner Imaging of striatal dopamine release elicited with NMDA antagonists: is there anything there to be seen? , 2007, Journal of psychopharmacology.

[36]  J. Krystal Ketamine and the potential role for rapid-acting antidepressant medications. , 2007, Swiss medical weekly.

[37]  C. Blakemore,et al.  Development of a rational scale to assess the harm of drugs of potential misuse , 2007, The Lancet.

[38]  C. Streutker,et al.  Ketamine-associated ulcerative cystitis: a new clinical entity. , 2004, Urology.

[39]  A. Winstock,et al.  5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users , 2006, European Addiction Research.

[40]  R. Griffiths,et al.  Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults. , 2006, Experimental and clinical psychopharmacology.

[41]  C. Morgan,et al.  Acute and chronic effects of ketamine upon human memory: a review , 2006, Psychopharmacology.

[42]  D. G. Critchlow A case of ketamine dependence with discontinuation symptoms. , 2006, Addiction.

[43]  J. Krystal,et al.  Greater vulnerability to the amnestic effects of ketamine in males , 2006, Psychopharmacology.

[44]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[45]  Garry D. Honey,et al.  Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits , 2006, Trends in Cognitive Sciences.

[46]  B. Brandner,et al.  Semantic Priming after Ketamine Acutely in Healthy Volunteers and Following Chronic Self-Administration in Substance Users , 2006, Biological Psychiatry.

[47]  W. Darrow,et al.  Risky sexual behaviors associated with recreational drug use among men who have sex with men in an international resort area: Challenges and opportunities , 2005, Journal of Urban Health.

[48]  C. Griffin,et al.  Ketamine: The divisive dissociative , 2006 .

[49]  Mark Slifstein,et al.  Altered prefrontal dopaminergic function in chronic recreational ketamine users. , 2005, The American journal of psychiatry.

[50]  E. Nestler Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[51]  M. Sullivan,et al.  Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. , 2005, The journal of pain : official journal of the American Pain Society.

[52]  K. Shelton Substitution profiles of N-methyl-D-aspartate antagonists in ethanol-discriminating inbred mice. , 2004, Alcohol.

[53]  A. Becker,et al.  Increased neurogenesis in a rat ketamine model of schizophrenia , 2004, Biological Psychiatry.

[54]  R. Gable Acute Toxic Effects of Club Drugs , 2004, Journal of psychoactive drugs.

[55]  Edward J Gracely,et al.  Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. , 2004, Pain medicine.

[56]  K. Marquis,et al.  Effects of fixed ratio size and dose on phencyclidine self-administration by rats , 2004, Psychopharmacology.

[57]  C. Morgan,et al.  Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study , 2003, Psychopharmacology.

[58]  H. Schroeder,et al.  Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  J. Copeland,et al.  Patterns of use and harms associated with non-medical ketamine use. , 2003, Drug and alcohol dependence.

[60]  D. Lim,et al.  Ketamine associated psychedelic effects and dependence. , 2003, Singapore medical journal.

[61]  H. Pal,et al.  Ketamine dependence. , 2002, Anaesthesia and intensive care.

[62]  S R Hursh,et al.  Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. , 2002, The Journal of pharmacology and experimental therapeutics.

[63]  J. Arditti,et al.  [Ketamine--dreams and realities]. , 2002, Acta clinica Belgica.

[64]  I. Ben-Shlomo,et al.  Intravenous midazolam significantly enhances the lethal effect of thiopental but not that of ketamine in mice. , 2001, Pharmacological research.

[65]  C. E. Stewart Ketamine as a street drug. , 2001, Emergency medical services.

[66]  H. Curran,et al.  In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. , 2001, Addiction.

[67]  Patrick M. O'Malley,et al.  Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .

[68]  K. Jansen,et al.  A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences , 2000, Journal of psychoactive drugs.

[69]  M. Abdel‐Rahman,et al.  Teratogenic effect of ketamine and cocaine in CF-1 mice. , 2000, Teratology.

[70]  C. Morgan,et al.  Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. , 2000, Addiction.

[71]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[72]  M. Tsuda,et al.  Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. , 2000, Life sciences.

[73]  S. Rothrock,et al.  Inadvertent ketamine overdose in children: clinical manifestations and outcome. , 1999, Annals of emergency medicine.

[74]  J. Bostwick,et al.  Ketamine dependence in anesthesia providers. , 1999, Psychosomatics.

[75]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and haloperidol in healthy humans , 1999, Psychopharmacology.

[76]  M. Tsuda,et al.  Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. , 1999, Life sciences.

[77]  J. Krystal,et al.  Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. , 1998, Archives of general psychiatry.

[78]  B. Rocha,et al.  Discriminative stimulus effects of diazepam, ketamine and their mixture: ethanol substitution patterns , 1998, Behavioural pharmacology.

[79]  N. Volkow,et al.  Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects , 1998, Neuropsychopharmacology.

[80]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[81]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[82]  E. Krupitsky,et al.  Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. , 1997, Journal of psychoactive drugs.

[83]  F. Vollenweider,et al.  Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.

[84]  A. Malhotra,et al.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.

[85]  D. Shewan,et al.  Illicit use of ketamine in Scotland. , 1996, Journal of psychoactive drugs.

[86]  A. Percy,et al.  The 1996 British Crime Survey: England and Wales , 1996 .

[87]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[88]  D. Fujikawa Neuroprotective Effect of Ketamine Administered After Status Epilepticus Onset , 1995, Epilepsia.

[89]  Hurt Ph,et al.  A case of ketamine dependence. , 1994 .

[90]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[91]  E. Ritchie,et al.  A case of ketamine dependence. , 1994, The American journal of psychiatry.

[92]  K. Berridge,et al.  The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.

[93]  O. Paulsen,et al.  Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. , 1992, The Journal of pharmacology and experimental therapeutics.

[94]  K. Jansen Ketamine--can chronic use impair memory? , 1990, The International journal of the addictions.

[95]  T. Hilden,et al.  The psychotropic effect of ketamine. , 1988, Journal of psychoactive drugs.

[96]  A. B. Gould,et al.  Development of tolerance to ketamine in an infant undergoing repeated anesthesia. , 1981, Anesthesiology.

[97]  A. Waterman,et al.  THE DEVELOPMENT OF TOLERANCE TO KETAMINE IN RATS AND THE SIGNIFICANCE OF HEPATIC METABOLISM , 1978, British journal of pharmacology.

[98]  Siegel Rk Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978 .

[99]  Nolan Miller,et al.  The Scientist: A Novel Autobiography , 1978 .

[100]  R. K. Siegel Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978, NIDA research monograph.

[101]  J. F. Cumming,et al.  The Development of an Acute Tolerance to Ketamine , 1976, Anesthesia and Analgesia.

[102]  G. Corssen,et al.  Safety and Tolerance of Repeated Anesthesia with CI 581 (Ketamine) in Monkeys , 1967, Anesthesia and analgesia.